AlloCyte Pharmaceuticals AG

TOPADUR Pharma AG, located in Schlieren, was founded in 2015 by experienced R&D scientists. Topadur discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to treat aging-related diseases as chronic wounds, glaucoma, colorectal cancer, Alopecia and skin aging.

Jantar is a clinical R&D company in the field of chronic rhinosinusitis. Its product is a nasal spray of dicholine succinate. Clinical efficacy has been demonstrated by well-documented case studies which showed that the drug relieves all symptoms of the disease. A PCT patent has been filed.

Mabylon is leading innovation in human-derived antibody therapeutics for severe allergies, inflammation, and neurological disorders. MY006, our first-in-class multi-specific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.